The NETS
TA-25 Index (TAV),
an exchange-traded fund (ETF), tracks the TA-25,
the Tel-Aviv Stock Exchange's principal index of 25 large capitalization
stocks. TAV began trading on May 21, 2008.
The top sectors include financials, materials, telecommunications
and health care.
Teva Pharmaceuticals,
one of the world's largest generic pharmaceutical companies, makes
up 10.58 percent of TAV by percent net assets followed by Bank
Hapoalim. (9.76%), Bank
Leumi Le-Israel (9.75%), Israel
Chemicals Limited (8.99%) and Israel
Corporation (6.91%).
TAV on July 25 closed at $22.13, down from its all-time high of
$25.50 set on June 17, 2008 (price
chart).
TAV has an expense ratio of 0.70 percent.
Related Articles:
Claymore BNY/Mellon Frontier
Markets ETF Offers Exposure to 17 Frontier Markets
iShares MSCI Israel Capped
Investable Market Index Holds Major Israeli Stocks
Market Vectors-Africa Index
ETF Features 11 African Countries
Market Vectors Gulf States
Index ETF Includes Gulf Cooperation Council Stocks
Own MENA (Middle East, North Africa)
Stocks With Eight ETFs
PowerShares MENA Frontier
Countries Portfolio Includes Middle East Stocks
SPDR S&P
Emerging Middle East & Africa Features South African and Israeli
Stocks
WisdomTree
Middle East Dividend Fund Begins Trading
Updated August 15, 2008.
|
